Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1 Nasopharyngeal Carcinoma 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 42 lenvatinib 21 Fluorouracil 16 atezolizumab 15 Oxaliplatin 14 Bevacizumab 13 Doxorubicin 12 Radiosurgery 11 Leucovorin 11 Radiofrequency Ablation 10 Ethiodized Oil 10 pembrolizumab 7 Folfox protocol 7 sintilimab 6 durvalumab 6 Radiotherapy 6 Nivolumab 6 Epirubicin 6 Cisplatin 6 tremelimumab 5 Gemcitabine 5 apatinib 4 Embolization, Therapeutic 4 tislelizumab 3 camrelizumab 3 cabozantinib 3 Tenofovir 3 Pharmaceutical Preparations 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Hepatocellular × lobaplatin × Clear all

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡